VOGLISTAR MD 0.3 10.S

About

Voglistar MD 0.3 is an orally disintegrating tablet containing Voglibose 0.3mg, an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. Voglibose works by delaying the digestion and absorption of carbohydrates from the gastrointestinal tract. It achieves this by competitively inhibiting alpha-glucosidase enzymes located in the brush border of the small intestine, which are responsible for breaking down complex carbohydrates into absorbable monosaccharides. By slowing down this process, Voglibose reduces the postprandial rise in blood glucose levels, which is particularly beneficial for patients experiencing significant spikes after meals. The orally disintegrating formulation offers convenience and may be particularly useful for patients who have difficulty swallowing conventional tablets. Voglistar MD 0.3 is typically prescribed as an adjunct to diet and exercise, either as monotherapy or in combination with other antidiabetic agents, to improve glycemic control.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of postprandial blood glucose levels.
• Used as an adjunct to diet and exercise.
• As monotherapy or in combination therapy.

Directions For Use

Place the orally disintegrating tablet on the tongue, allow it to dissolve, and then swallow with saliva, usually immediately before meals.

Benefits

• Effectively reduces post-meal blood sugar spikes.
• Delays carbohydrate absorption.
• Low risk of hypoglycemia when used alone.
• Convenient orally disintegrating formulation.
• Can be used in combination with other antidiabetics.
• Helps improve overall glycemic control.

Side Effects

• Flatulence
• Abdominal distension
• Diarrhea
• Abdominal pain
• Nausea
• Vomiting
• Heartburn
• Constipation
• Skin rash (rare)
• Hepatitis (rare)
• Increased liver enzymes (rare)
• Hypoglycemia (when combined with sulfonylureas/insulin)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake should be avoided as it may affect blood sugar levels.
• Pregnancy - Consult your doctor. This medication is generally not recommended during pregnancy unless clearly necessary, as its safety has not been fully established.
• Breastfeeding - Consult your doctor. It is unknown if Voglibose passes into breast milk, and its use during breastfeeding should be carefully considered.
• Liver - Use with caution in patients with liver impairment. Regular monitoring of liver function tests is recommended during treatment.
• Kidney - Use with caution in patients with severe kidney impairment. Your doctor will assess suitability and dosage.
• Lung - No specific contraindications, but general health should be considered.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.